Showing 6,049 results

Filters Content type: News, Editors' picks, About HIV Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

Kidney problems

Tenofovir treatment impairs kidney function, but clinical significance limited

News
16 August 2010
Mental & emotional health problems

Symptoms can predict increases in viral load for patients taking HIV treatment

News
9 August 2010
Starting treatment

FDA Approves New Labeling For ISENTRESS® To Include 96-Week Efficacy And Tolerability Data In Adult Patients Infected With HIV-1

Editor's pick
Medical News Today
6 August 2010
Changing treatment

AFRICA/ASIA: Worrying rates of second-line treatment failure

Editor's pick
IRIN Plus News
4 August 2010
Government, leadership & policy

Lymphocyte count and haemoglobin can predict prognosis of patients starting ART

News
3 August 2010
Treatment outcomes & life expectancy

Outcomes still improving for HIV patients in the UK

News
2 August 2010
New & experimental HIV treatments

Chimerix's CMX157 Shows Potential to Treat Multi-Drug-Resistant HIV and Improve the Activity and Toxicity Profile of Tenofovir

Editor's pick
PR Newswire
28 July 2010
New & experimental HIV treatments

Therapeutic HIV vaccines show promise

Editor's pick
Scientific American
28 July 2010
Epidemiology

'The business of public health': new research on financing of HIV programmes

News
27 July 2010
New & experimental HIV treatments

Good results seen with NRTI-sparing regimens of atazanavir plus newer drug classes

News
26 July 2010
Neurological & cognitive problems

Neurocognitive impairment linked to prior low CD4 cell count, even if on current suppressive HIV treatment

News
26 July 2010
Starting treatment

CASCADE analysis finds antiretroviral treatment benefits are evident below CD4 count of 500, uncertain above this level

News
23 July 2010
New & experimental HIV treatments

Once-daily extended-release nevirapine works as well as twice-daily formulation

News
23 July 2010
New & experimental HIV treatments

Experimental integrase inhibitor GSK-572 shows continued promise

News
23 July 2010
HIV treatment

Rilpivirine (TMC278) matches efavirenz in phase 3 studies, with fewer side-effects

News
22 July 2010
Drug interactions & pharmacokinetics

IAC: Smoking Has No Impact on Atazanavir Levels

Editor's pick
MedPage Today
22 July 2010
Changing treatment

Protease inhibitor to raltegravir switch maintains viral suppression, but NRTI resistance lowers efficacy

News
22 July 2010
Pregnancy, children & young people

Low birth weight seen in small minority of infants exposed to some antiretroviral drugs

News
22 July 2010
HIV treatment

IAC: Nano-Sized Efavirenz Looks Doable

Editor's pick
MedPage Today
21 July 2010
Health problems in children & young people

Children with HIV are at risk for metabolic problems and heart muscle dysfunction

News
21 July 2010
New & experimental HIV treatments

TBR-652 blocks both CCR5 and CCR2, inhibiting HIV replication and reducing inflammation

News
20 July 2010
Epidemiology

Universal access to HIV treatment threatened by failure of will

News
20 July 2010
Support issues for children & young people

Adolescents living with HIV face complex psychosocial concerns: require targeted, comprehensive services

News
20 July 2010
Side effects

IAC: Docs Talk But Fail to Communicate HIV Knowledge (CME/CE, with video)

Editor's pick
MedPage Today
20 July 2010